Safety and Efficacy of Dexamethasone Intravitreal Implant in Korea

Trial Profile

Safety and Efficacy of Dexamethasone Intravitreal Implant in Korea

Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2016

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Branch retinal vein occlusion; Central retinal vein occlusion
  • Focus Adverse reactions
  • Sponsors Allergan
  • Most Recent Events

    • 12 Jan 2016 Primary end point "Best Corrected Visual Acuity" is now removed so trial focus changed from TU + AR to AR. Also treatment for non-infectious uveitis affecting the posterior segment of the eye is now added so change in inclusion criteria and treatment according to record.
    • 22 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.
    • 30 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top